Malignant Large Intestinal Neoplasm — Research

Malignant Large Intestinal Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	486	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	7	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	1	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (370)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 201–225 of 370 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.
· Eur J Cancer · 2016 · PMID 26812186 · validated civic_curation pubmed
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
· J Clin Oncol · 2015 · PMID 26460303 · validated civic_curation pubmed
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
· Lancet · 2012 · PMID 22608338 · validated civic_curation pubmed
Cetuximab for the treatment of colorectal cancer.